Eden Biodesign becomes cGMP provider for PER.C6 technology
Crucell and Eden Biodesign have entered into an agreement that sees Eden become a provider of services of contract manufacturing services for Crucell's PER.C6 cell-line technology.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs